• DaVita will present seven studies at American Society of Nephrology Kidney Week 2026, with presentations scheduled for Oct. 22-24.
• Two expanded hemodialysis studies suggest the therapy could benefit a broad patient population while preserving albumin levels.
• A peritoneal dialysis study links treatment completion following hospital discharge to reduced cumulative hospitalizations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DaVita Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610150900PR_NEWS_USPR_____LA72930) on October 15, 2026, and is solely responsible for the information contained therein.